StockData
Johnson & Johnson logo

Johnson & Johnson

JNJNYSEPharmaceutical PreparationsFiscal year ends January 3
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Oct 21, 2026Score 12/3043% above fair value
$270.56−2.64 (-0.97%)

Close on Nov 2, 2026Market cap $652.02BP/E 31.4Yield 1.90%

Johnson & Johnson J&J Savings Plan by Year

J&J Savings Plan — Notes receivable from participants / loans ($) ($)

Johnson & Johnson J&J Savings Plan: $96,395,432 in FY2025, up 2.8% from a year earlier.

Latest, FY2025
96,395,432
Period ended Dec 28, 2025
Change on a year earlier
+2.8%
93,770,955 in FY2024
History
8 years
Since FY2018
Sources
7
Documents cited below

Where the FY2025 figure comes from

“|| Notes receivable from participants | 96,395,432 | 93,770,955”

Source: Form 11-K (Savings Plan) (jnj-20260624.htm, filed 2026-06-25) ↗

Reported in Form 11-K Audited Financial Statements.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

Cite this data

StockData. (2026). Johnson & Johnson J&J Savings Plan ($), annual FY2018–FY2025 [Data set]. Compiled from Johnson & Johnson SEC filings and investor materials. https://stockdatahq.com/stocks/jnj/kpis/sp-notes-rec

See every metric in the Johnson & Johnson KPI table. Data updated Oct 25, 2026.